Detalles de la búsqueda
1.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
N Engl J Med
; 385(23): 2123-2131, 2021 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874631
2.
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Breast Cancer Res Treat
; 201(2): 151-159, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338729
3.
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.
Invest New Drugs
; 41(5): 677-687, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556023
4.
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601.
Int J Gynecol Cancer
; 33(6): 929-936, 2023 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759001
5.
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Int J Mol Sci
; 24(13)2023 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37446361
6.
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
BMC Cancer
; 22(1): 1150, 2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36348385
7.
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.
Anticancer Drugs
; 30(6): 628-635, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31008727
8.
Feasibility and safety of a modified outpatient regimen with intravenous/intraperitoneal chemotherapy for optimally debulked stage III ovarian cancer.
Int J Gynecol Cancer
; 25(2): 214-21, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25415075
9.
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).
Clin Cancer Res
; 30(1): 176-186, 2024 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37527007
10.
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Clin Transl Oncol
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578537
11.
Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program.
Gynecol Oncol Rep
; 48: 101211, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37396679
12.
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.
J Clin Med
; 12(16)2023 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37629305
13.
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol
; 15: 17588359221148921, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36743520
14.
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Eur J Cancer
; 182: 3-14, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36706655
15.
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Clin Transl Oncol
; 25(7): 2090-2098, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708371
16.
A Smart Digital Health Platform to Enable Monitoring of Quality of Life and Frailty in Older Patients with Cancer: A Mixed-Methods, Feasibility Study Protocol.
Semin Oncol Nurs
; 39(3): 151437, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149438
17.
SEOM-GEICO clinical guidelines on endometrial cancer (2021).
Clin Transl Oncol
; 24(4): 625-634, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35312947
18.
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study.
Eur J Cancer
; 172: 340-348, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830841
19.
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy.
Cancers (Basel)
; 14(12)2022 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740602
20.
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
Eur J Cancer
; 168: 12-24, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429901